Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term randomized double-blind study of lemborexant in adults with insomnia disorder
2015-001463-39Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lemborexant in Insomnia (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Mean change from baseline in subjective sleep onset latency at Month 6. Started Nov 2016; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2015-001463-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001463-39.